
JPXBasic MaterialsChemicals - Specialty
最新データ
¥1,468.5
+¥24.00 · +1.66%
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
最新データ
¥1,468.5
+¥24.00 · +1.66%
日中の時刻はJSTです。市場データは遅延する場合があります。
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
日中レンジ
現在 ¥1,468.5
52週レンジ
現在 ¥1,468.5
日中の時刻はJSTです。市場データは遅延する場合があります。
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
日中レンジ
現在 ¥1,468.5
52週レンジ
現在 ¥1,468.5
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(JPY) | 2026年度 | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|---|
| 売上高 | 5796.29億 JPY | 5865.31億 JPY | 5580.56億 JPY | 5380.26億 JPY | 4679.37億 JPY |
| 売上原価 | 4333.4億 JPY | 4206.93億 JPY | 3976.69億 JPY | 3909.82億 JPY | 3282.55億 JPY |
| 粗利益 | 1462.89億 JPY | 1658.38億 JPY | 1603.87億 JPY | 1470.44億 JPY | 1396.82億 JPY |
| 研究開発 | — | 259.31億 JPY | 233.93億 JPY | 218.78億 JPY | 207.41億 JPY |
| 販売・一般管理 | 1042.19億 JPY | 788.96億 JPY | 746.01億 JPY | 776.57億 JPY | 682.43億 JPY |
| 営業費用 | 1042.19億 JPY | 1048.27億 JPY | 979.94億 JPY | 995.35億 JPY | 889.84億 JPY |
| 受取利息 | 8.16億 JPY | 12.05億 JPY | 15.65億 JPY | 6.97億 JPY | 2.36億 JPY |
| 支払利息 | 31.98億 JPY | 19.83億 JPY | 16.68億 JPY | 14.33億 JPY | 13.61億 JPY |
| 減価償却費と償却費 | 433.43億 JPY | 413.73億 JPY | 337.03億 JPY | 315.75億 JPY | 281.95億 JPY |
| 営業利益 | 420.7億 JPY | 610.11億 JPY | 623.93億 JPY | 475.09億 JPY | 506.98億 JPY |
| 純利益 | 101.81億 JPY | 494.81億 JPY | 558.35億 JPY | 406.83億 JPY | 312.54億 JPY |
会社概要が更新されました 2026年10月16日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
NEXT FUNDS TOPIX Exchange Traded Fund1306.T91.23億0.03%34.2兆 JPY0.05%¥428+1.66%
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T9.11億0.04%2.31兆 JPY0.11%¥36,930+1.51%
iShares Core TOPIX ETF1475.T8.14億0.03%2.93兆 JPY0.05%¥421.3+1.62%
iShares JPX-Nikkei 400 ETF1364.T2.48億0.04%6029.03億 JPY0.05%¥3,803+1.49%
Avantis International Small Cap Value ETFAVDV5134.56万0.26%198.75億 USD0.36%$107.31+0.03%
Vanguard Total International Stock ETFVXUS3051.22万0.00%6657億 USD0.05%$83.84+0.31%
Vanguard FTSE Developed Markets ETFVEA1985.18万0.01%3135億 USD0.03%$69.66+0.52%
iShares Core MSCI EAFE ETFIEFA1619.14万0.01%1885.6億 USD0.07%$96.62+0.78%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T
iShares Core TOPIX ETF1475.T
iShares JPX-Nikkei 400 ETF1364.T
Avantis International Small Cap Value ETFAVDV
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Developed Markets ETFVEA
iShares Core MSCI EAFE ETFIEFAAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。